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A novel system to study early hematopoietic development is described. This report documents the in vitro 
capacity of murine embryonic stem (ES) cells to differentiate into hematopoietic precursors of most,  if not all, 
of the colony-forming cells found in normal bone marrow. This system is used to correlate the genetic 
expression of cytokines, their receptors, the 13-globins, and the hematopoietic cell surface markers throughout 
the time course of ES cell differentiation with the hematopoietic development that occurs in these cultures. 
Our results indicate that there is a strong transcriptional activation, in a well-defined temporal order, of most 
of these genes including erythropoietin (Epo), CSF-1, IL-4, IL-6, I~-globins, as well as the receptors for Epo, 
CSF-I, and IL-4. IL-3 and GM-CSF were not expressed during the first 24 days of ES cell differentiation. In 
contrast, the Steel (S/) factor (SLF) was expressed early and underwent substantial up-regulation during this 
differentiation, and its receptor, c-kit, was expressed relatively constantly throughout the culture period. Our 
results are consistent with the conclusion that SLF, Epo, IL-4, and IL-6 are important during the early stages 
of ES cell differentiation and hematopoietic development. Furthermore, these results argue strongly that IL-3 
and GM-CSF are not critical to early hematopoiesis. This system offers a unique in vitro model for studying 
hematopoietic development at the earliest possible stages. 
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Most mature blood cells are short lived and must be 
replaced continuously throughout adult life from a self- 
renewing population of pluripotent hematopoietic stem 
cells located mainly in the bone marrow. These stem 
cells produce progenitor cells committed to one of the 
hematopoietic lineages (Micklem and Ogden 1976; 
Abramson et al. 1977), including erythrocytes, mega- 
karyocytes, granulocytes, monocytes, and lymphocytes. 
The first fetal hematopoietic precursors appear in the 
yolk sac (Russell 1979). As development proceeds the 
major site of hematopoiesis shifts to the fetal liver and 
subsequently to the bone marrow. In contrast to the 
large body of data available on the control of adult he- 
matopoiesis, very little is known about the induction 
and control of fetal hematopoietic development or about 
what growth factors are involved during this stage of 
development. This is caused in part by the lack of a suit- 
able in vitro experimental system. 
Many cytokines have been shown to be important to 
hematopoietic development, such as erythropoietin 
(Epo) (Iscove and Sieber 1975), granulocyte colony-stim- 
ulating factor (G-CSF) (Nicola et al. 1983), macrophage- 
CSF (M-CSF or CSF-1)(Stanley and Heard 1977), granu- 
locyte/macrophage-CSF (GM-CSF) (Metcalf et al. 1980), 
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2CorFesponding author. 
interleukin 1 (IL-1){Mochizuki et al. 1987}, IL-3 {Iscove 
and Roitsch 1985}, IL-4 (Paul and Ohara 1987}, and IL-6 
{Wong et al. 1988). These factors range from being lin- 
eage specific, such as Epo and CSF-1, to acting on mul- 
tiple lineages, such as IL-3 and GM-CSF. The recently 
described Steel factor (SLF) (Anderson et al. 1990; Zsebo 
et al. 1990) and its receptor, c-kit (Chabot et al. 1988; 
Geissler et al. 1988), are critical to hematopoietic, germ 
cell, and melanocyte development, although their pre- 
cise functions during development are not clear (Russell 
1979; Silvers 1979). 
Embryonic stem (ES) cells are totipotent cells that are 
derived from the inner cell mass of mouse blastocysts 
and can be kept apparently indefinitely in culture (Evans 
and Kaufman 1981; Martin 1981; Suda et al. 1987). If 
injected into mouse blastocysts these cells contribute to 
all tissues, including the germ cells, of the developing 
animal (Bradley et al. 1984). ES cells are kept undiffer- 
entiated by coculture with feeder cells (Martin and Evans 
1975a, b) or by addition of leukemia inhibitory factor 
(LIF), which inhibits their differentiation (Williams et al. 
1988). If LIF is withdrawn, ES cells undergo differentia- 
tion culminating in complex cystic embryoid bodies 
with endoderm, mesoderm, and ectoderm resembling 
the 6- to 8-day egg cylinder stage in normal embryonic 
development. These embryoid bodies contain two of the 
major products of the visceral yolk sac, oL-fetoprotein and 
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transferrin, and some develop visible blood islands 
(Doetschman et al. 1985). Little more is known about the 
hematopoietic development that occurs in this system. 
Identifying the regulatory controls of this early he- 
matopoietic development would contribute greatly to 
our overall understanding of the biology of the he- 
matopoietic system. 
This communication reports the temporal hematopoi- 
etic development of ES cells as analyzed by colony for- 
mation in methylcellulose and by the expression of 
genes known to be influential during hematopoietic de- 
velopment. Neither IL-3 nor GM-CSF, two factors that 
have effects on immature hematopoietic cells, were ex- 
pressed during ES cell differentiation, although the prim- 
itive precursor of multilineage colonies was produced. 
This led to the hypothesis that IL-3 and GM-CSF were 
not required and prompted us to analyze the expression 
of additional factors, including IL-4, IL-6, and SLF, which 
have been shown to enhance hematopoiesis (Wong et al. 
1988; Rennick et al. 1989; Anderson et al. 1990; Zsebo et 
al. 1990). In addition to yielding new information on he- 
matopoietic development, these studies demonstrate 
that this novel in vitro system offers a unique opportu- 
nity to study the control of hematopoietic development 
at the earliest stages when hematopoietic cells are dif- 
ferentiating from their nonhematopoietic precursors. 
cultures at various times and evaluated by methylcellu- 
lose colony assays. These studies indicated that differ- 
entiating ES cells are able to produce most if not all of 
the colony-forming cells found in normal bone marrow. 
Figure 1 is an example of a May-Grfinwald-Giemsa stain 
of a smear from a mixed colony from ES cells that were 
differentiated for 16 days in vitro. This colony was de- 
rived from a multipotential precursor that gave rise to 
erythrocytes, macrophages, neutrophils, and cells with 
basophilic granules that, because of the culture condi- 
tions, are probably mast cells. Other hematopoietic col- 
onies were produced in ES cell differentiation cultures, 
including erythroid, macrophage, neutrophil, mast cell, 
as well as colonies containing granulocytes and macro- 
phages. In addition to the hematopoietic colonies, non- 
hematopoietic colonies were detected but not identified. 
To study the time course and extent of hematopoietic 
development, we quantitated the colony-forming cells 
that developed during ES cell differentiation from 0 to 28 
days. Starting at day 12 it was possible to separate the 
macroscopically visible hollow cysts from the nonhol- 
low structures. In general, >90% of the hematopoietic 
colony-forming precursors were associated with the 
large cysts; therefore, only the colony data from the cysts 
are shown from day 12 on. For the gene expression stud- 
Results 
ES cell system 
Each of three independent murine ES cell lines that we 
have studied is capable of differentiating into hematopoi- 
etic cells. In this communication we report the results 
using the 1E6/2 ES cell line. ES ceils are induced to dif- 
ferentiate by the combined effects of removing the dif- 
ferentiation inhibiting factor (LIF) and maintaining the 
ES cells in suspension cultures. These effects together 
with critical cell-cell interactions induce the formation 
of complex embryoid bodies that develop blood islands. 
Blood-island formation becomes obvious starting around 
day 8 of differentiation and is correlated with the devel- 
opment of microscopically distinct clusters of uniformly 
round cells within the developing cysts. Kemler and col- 
leagues reported that human cord serum (HCS) dramat- 
ically improves the blood island development in ES cell 
differentiation cultures (Doetschman et al. 1985). We 
have confirmed those results and have observed that 
HCS also has a dramatic promoting effect on the devel- 
opment of in vitro colony-forming cells (see below). In 
optimal cultures, 5-30% of the cysts have visible blood 
islands at any one time, although most if not all cysts 
will eventually develop them (data not shown). 
In vitro development of hematopoietic colonies from 
ES cells 
To investigate their hematopoietic potential, single cell 
suspensions were prepared from ES cell differentiation 
Figure 1. Cytological analysis of an ES cell-derived mixed col- 
ony. A smear was prepared from a methylcellulose-derived 
mixed colony that developed from day-16 differentiated ES 
cells. The slide was air-dried and stained with May-Grfinwald- 
Giemsa by standard techniques. (E) Erythroid precursor; {M) 
macrophage; IN) neutrophil; {G) cells with basophilic granules 
which, because of the culture conditions, are most probably 
mast cells. 
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ies, data from both the cysts and the noncysts are pre- 
sented. Figure 2 illustrates the development of he- 
matopoietic colony-forming cells from differentiating ES 
cells in three separate time course experiments from day 
2-28. We have not seen hematopoietic colonies from ES 
cells differentiated for <2 days. Colony data from day 12 
and day 16 of differentiation from two additional exper- 
iments are also included. For these figures we have com- 
bined the data for all of the various myeloid colonies, 
that is, pure macrophage, pure neutrophil, pure mast 
cell, and the colonies derived from the more immature 
precursors containing combinations of these cells under 
the category of granulocyte/macrophage. Although there 
was variation in the onset, extent, and duration, signifi- 
cant hematopoietic development occurred in all five ex- 
periments. 
Our data indicate that there are significant differences 
between ES cell and bone marrow-derived colony-form- 
ing units (CFU). Based on a percentage of total he- 
matopoietic colonies from six experiments, ES cell 
differentiation cultures yielded 31 + 12% mixed, 
48 + 12% erythroid, 8 --- 8% single lineage myeloid 
(macrophage, neutrophil, or mast cell), and 17 + 4% GM 
colonies (Fig. 2 and data not shown). This compares with 
1.0 --+ 1% mixed, 1.7 +- 1% erythroid, 69 + 4% single 
lineage myeloid (macrophage, neutrophil, or mast cell), 
and 28 + 3% GM colonies from C57BL/6 normal bone 
marrow in 10 experiments (data not shown). This repre- 
sents a dramatic increase in the frequency of the primi- 
tive mixed and erythroid colonies, and a decrease in the 
mature single lineage myeloid colonies in differentiating 
ES cell cultures compared with adult bone marrow. 
HematopoietJc cell-surface marker expression 
The frequency of cells expressing hematopoietic surface 
markers was evaluated by flow cytometry. CD45 (Ly-5) 
is a surface marker that is expressed on almost all he- 
matopoietic cells (Miller et al. 1985; Thomas 1989), 
whereas Thy-1 is expressed on T cells, immature he- 
matopoietic precursors, and some neural cells (Reif and 
Allen 1964; Berman and Basch 1985). Ly-6A (Sea-l) is 
expressed on lymphocytes, bone marrow cells, neutro- 
phils, macrophages, and hematopoietic stem cells (She- 
vach and Korty 1989; van de Rijn et al. 1989). Table 1 
lists the results of fluorescence-activated cell sorting 
(FACS) analyses of differentiated ES cells. Of the cells 
from day 16--24 cysts, 2% were CD45 +, 1% were 
Thy-1 +, and 0.8% expressed Ly-6A. There was no ex- 
pression above background of the neutrophil marke r  
RB6-8C5 (Coffman 1982), the macrophage marker MAC- 
1 (Springer et al. 1978), or the antigen that is found on B 
cells and hematopoietic stem cells, AA4.1 (Jordan et al. 
1990) (Table 1). There was no consistent significant ex- 
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Figure 2. Hematopoietic colony formation from differentiated 
ES cells. ES cells were taken at the days of differentiation cul- 
ture as indicated, and single-cell suspensions were assayed in 
methylcellulose cultures as described in Materials and meth- 
ods. Hematopoietic colonies counted on day 8 (d8) of the 
methylcellulose cultures are shown. From day 12 of ES cell 
differentiation on, only the colony data originating from the 
macroscopically visible hollow cysts are presented. Three sep- 
arate time courses (solid box, time course l; shaded box, time 
course 2; checked box, time course 3) and single time points 
from two additional experiments I*l are shown. {A) Mixed col- 
onies; (B) erythroid colonies, i.e., erythroid burst-forming units 
(BFU-E)~ (C) granulocytic-monocytic colonies (including dual- 
lineage GM-type, as well as pure granulocytic and monocytic 
colonies) formed by the differentiating ES cells. 
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Table 1. Hematopoietic marker analysis of differentiated 
ES ceils 
Percent positive cells ~ 
Marker undifferentiated differentiated bone 
(antibody) b ES cells ES cells spleen marrow 
CD45 {Ly-5) - -  1.8 c 100 nd 
Thy- 1 - -  1.0 40 nd 
Ly-6A - -  0.8 72 6 
B220 - -  - -  43 nd 
RB6-8C5 --  - -  nd 67 
MAC- 1 - -  - -  nd 65 
AA4. I - -  - -  nd 19 
~Undifferentiated and differentiated ES cells from day 16-25 of 
differentiation were trypsinized to give single cell suspensions, 
stained, and analyzed as described in Materials and methods. 
The results represent the data from one to three experiments. 
(--) <0.5%; (nd) not done. 
bSee Materials and methods. 
~Average of three experiments from days 16-25. 
pression of the B-cell lineage marker  B220 (Coffman and 
Weissman 1981), but in some experiments  very smal l  
(0.3-0.5%) differences from the background were de- 
tected, which  were not  observed wi th  other negative an- 
tibodies. 
Gene expression during ES cell differentiation 
To understand better the growth control of hematopoi- 
etic cells during the in vitro differentiation of ES cells, 
we investigated the expression of a number  of genes 
known to be involved in adult hematopoiesis.  The t ime 
point at which  a particular factor and its receptor under- 
goes significant expression will  suggest when  that factor 
begins to play a role in the differentiation process. Like- 
wise, the lack of expression of a particular cytokine and 
its receptor would be strong evidence that the factor is 
not critical for development at that stage. Expression 
studies were accomplished by using reverse tran- 
scriptase-dependent polymerase chain reaction (RT- 
PCR) (Ohara et al. 1989) to determine the relative steady- 
state m R N A  levels throughout the developmental  t ime 
course. The analysis of gene expression was performed 
on t ime courses 1 and 2, as well  as selected t ime points 
from other experiments.  With exception to the exact day 
of onset of expression, all of the results were comparable; 
therefore, only the data from t ime course 2 are presented 
in Figures 3-7. We included several normal  tissues and 
cell l ines as controls, including STO cells that are used 
many  t imes to ma in ta in  undifferentiated ES cells {Mar- 
t in and Evans 1975a). Except during the ini t ia l  isolation, 
all of our ES cell cultures were main ta ined  without  
feeder cells of any kind. As discussed in Materials  and 
methods, all of our experiments  were standardized by 
B-actin amplif icat ion (Fig. 3). All of the results to be de- 
scribed below are summarized  in Table 2, which  lists 
these genes according to their temporal order of expres- 
sion. 
The expression of B-globin is obvious in the develop- 
ing cysts by the visual appearance of hemoglobin.  This  
expression was confirmed by analyses of B-globin RNA 
levels. Figure 4 shows the result  of the RT-PCR ampli-  
fication of the fetal y and the adult  bl B-globin cDNAs 
during 24 days of differentiation. Nei ther  of these genes 
is expressed in undifferentiated ES ceils, and both un- 
dergo a strong induct ion during differentiation. The ex- 
pression of fetal globin predominates from the preculture 
stage through day 8, and then both fetal and adult  genes 
are expressed at significant levels throughout the rest of 
the t ime course {Fig. 4J. This  contrasts to the fact that  
mature erythroid methylce l lu lose  colonies derived from 
day 16 cysts expressed almost  exclusively adult  globin 
(data not shown). As observed wi th  several other genes, 
the globin genes are predominant ly  expressed in the 
large developing cysts. 
It is obvious by the colony assays that substantial  he- 
matopoietic development  is occurring during the differ- 
entiat ion of ES ceils. Another  indicat ion of hematopoie- 
tic development  is the appearance of CD45 [Ly-51, which  
is a surface marker  found on most  hematopoiet ic  cells. 
Primers designed to ampli fy  the 3' portion of the CD45 
gene, which  is present in all known forms of the mole- 
cule {Thomas 1989), were used to show that this gene 
0 
. . . .  O c o  , 
Figure 3. Expression of the B-actin gene during ES cell differ- 
entiation analyzed by RT-PCR. The PCR with primers specific 
for B-actin was performed for only 25 cycles to stay in the linear 
range of the amplification reaction. The faint band in day 12 
noncysts and day 20 cysts in the reverse transcriptase minus 
{neg. controll control is derived from contaminating genomic 
DNA. 
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T a b l e  2. Expression of genes related to hematopoiesis during ES cell differentiation a 
Differentiated ES cells b 
Gene undiff pre d2 d4 d8 d l2c  d16c d20c d24c 
c-kit +c + + + + + + + + + + + + + + + + 
SLF + + + + + + +  + +  + + +  + + +  
Thy-1 + + + + + + + + + + + + + + + + + +  + 
Epo receptor _ d + + + + + + + + + + + + + + 
Epo _ a + + + + + + + + + + + 
IL-4 receptor _ d + + + + + + + + + + + + + + 
B-Globin (fetal) - + + + + + + + + + + + + + + + + + 
CSF-1 - + +  - + + +  + +  + +  + + +  + + +  
IL-6 - + + - - - + + + + + + + + 
IL-4 - - + - - + + + + + + + + 
~-Globin (adult) - - ___ - + + + + + + + + + + + + 
IL-3 receptor - - - + + + + + + + + + + + + 
CSF-1 receptor . . . .  _+ + + + + + + + + + + 
IL-1-receptor . . . . .  + + + + + + + + + + 
CD45 (Ly-5) . . . . .  + + + + + + 
G-CSF receptor . . . . .  + + + + + + + + 
IL-I~ . . . . .  + + + + + + + + + 
G-CSF - + . . . . . . .  + + 
IL-let . . . . . . .  + _e 
GM-CSF . . . . . . . . .  
IL-3 . . . . . . . . .  
"Summary of the PCR data taken from Figs. 4-7 listed in the order of temporal appearance. 
b(undiff) Undifferentiated ES cell colonies picked by micromanipulat ion;  {pre) preculture as described in Materials and methods; (c) 
from day 12 on only the results from the cyst fraction are given. Note  that there are differences between cysts and noncysts in the 
expression of some genes that are not  reflected in this table (Figs. 4-6). 
CThis is to indicate a relative level of expression for a given gene during the t ime course of the experiment.  It must  be stressed that  
it is not  valid to use this data to compare the levels of expression of one gene with another; therefore, no effort was made to do so. 
din some, but not all, preparations of undifferentiated ES cells a weak expression of these genes was seen at high numbers of 
amplification cycles. 
eThere was a signal in the noncyst  fraction from this t ime point (Figs. 5 and 6). 
b e c o m e s  t r a n s c r i p t i o n a l l y  a c t i v e  a r o u n d  day  12, a n d  in- 
c reases  i ts  e x p r e s s i o n  up  to  day  24 of d i f f e r e n t i a t i o n  (Fig. 
4). A l t h o u g h  t h e  l eve l  of C D 4 5  e x p r e s s i o n  at  t h e  t e r m i -  
n a t i o n  of t h e  e x p e r i m e n t  w a s  s ign i f i can t ,  i t  w a s  s t i l l  w e l l  
b e l o w  t h a t  of t h e  h e m a t o p o i e t i c  t i s s u e  con t ro l s ,  s u c h  as 
b o n e  m a r r o w ,  l y m p h  node ,  a n d  l i p o p o l y s a c c h a r i d e  (LPS)- 
a c t i v a t e d  s p l e e n  cel ls ,  w h i c h  all  h a v e  g rea t e r  t h a n  90% 
C D 4 5  + cel ls .  T h e  l eve l  of C D 4 5  R N A  in  d i f f e r e n t i a t i n g  
ES ce l l s  is c o n c o r d a n t  w i t h  t h e  fac t  t h a t  o n l y  2% of day  
16 d i f f e r e n t i a t e d  cel ls  expres s  C D 4 5  sur face  m o l e c u l e s  
(Table  1). 
Thy-1  w a s  e x p r e s s e d  at  s i g n i f i c a n t  l eve l s  in  und i f fe r -  
e n t i a t e d  ES ce l l  s a m p l e s  ( this  is n o t  r e ad i l y  a p p a r e n t  in  
t h e  r e p r o d u c t i o n  of Fig. 4). A t  l a t e r  s tages  of ES ce l l  dif- 
f e r e n t i a t i o n ,  t h e  l eve l  of Thy-1  m R N A  e x p r e s s i o n  ap- 
p r o a c h e s  t h a t  s e e n  i n  n o r m a l  t i s sues ,  s u c h  as l y m p h  
n o d e ,  w h i c h  has  - 6 0 %  Thy-1  + cel ls .  T h i s  w a s  u n e x -  
p e c t e d  as w e  h a v e  n e v e r  o b s e r v e d  > 1% of t h e  d i f feren-  
t i a t e d  ES ce l l s  to  be Thy-1  + {Table 1). T h e  e x p l a n a t i o n  of 
t h i s  s e e m i n g l y  h i g h - l e v e l  " n o n p r o d u c t i v e "  t r a n s c r i p t i o n  
of t h e  thy-1 g e n e  is n o t  k n o w n .  
Expression of CSFs and their receptors 
D e t e r m i n i n g  t h e  e x p r e s s i o n  p a t t e r n s  d u r i n g  ES cel l  dif- 
f e r e n t i a t i o n  of t h e  c y t o k i n e s  a n d  t h e i r  r ecep to r s ,  w h i c h  
a re  k n o w n  to be i m p o r t a n t  to a d u l t  h e m a t o p o i e s i s ,  is 
f u n d a m e n t a l  to o u r  u n d e r s t a n d i n g  of t h e  i n d u c t i o n  and  
c o n t r o l  of h e m a t o p o i e t i c  d e v e l o p m e n t .  F igure  5 s h o w s  
t h e  R T - P C R  a n a l y s i s  of GM-CSF ,  Epo, CSF-1, G-CSF, 
a n d  the i r  r e c e p t o r s  [except  for  t h e  r e c e p t o r  for  GM-CSF,  
w h i c h  has  n o t  y e t  b e e n  c l o n e d  in  t h e  m o u s e l .  W i t h  t w o  
e x c e p t i o n s ,  n o n e  of t h e s e  m o l e c u l e s  are  exp re s sed  in  un -  
d i f f e r e n t i a t e d  ES cel ls .  A l t h o u g h  n o t  o b v i o u s  in  F igure  5, 
s o m e  e x p e r i m e n t s  sugges t  t h a t  Epo a n d  i ts  r e c e p t o r  are  
w e a k l y  t r a n s c r i b e d  in  s o m e  u n d i f f e r e n t i a t e d  samples .  It 
is l i k e l y  t h a t  th i s  l o w - l e v e l  s p o r a d i c  e x p r e s s i o n  in  undi f -  
f e r e n t i a t e d  ce l l s  of t h e s e  " e a r l y "  g e n e s  {Table 2) is a re- 
su l t  of t h e  p r e p a r a t i o n  c o n t a i n i n g  s m a l l  a m o u n t s  of dif- 
f e r e n t i a t e d  cells .  T h e  m a j o r  t r a n s c r i p t i o n a l  a c t i v a t i o n  of 
t h e s e  genes  o c c u r s  d u r i n g  t h e  p r e c u l t u r e  stage,  w h i c h  
d e m o n s t r a t e s  t h a t  d u r i n g  th i s  pe r iod ,  i n  a d d i t i o n  to ex- 
pand ing ,  t h e  ES ce l l  c o l o n y  beg ins  to  d i f f e ren t i a t e .  T h e  
o r ig in  of t h e  t w o  h y b r i d i z i n g  r e v e r s e  t r ansc r ip t a se -de -  
p e n d e n t  Epo b a n d s  fa i l ing  b e t w e e n  t h e  g e n o m i c  a n d  
c D N A  bands  o n  day  20--24 cys t s  [Fig. 5) is u n k n o w n ,  b u t  
t h e y  m a y  be r e l a t e d  to  sp l i c ing  i n t e r m e d i a t e s  t h a t  are  
o c c a s i o n a l l y  d e t e c t e d  in  t h e s e  P C R  ana lyses .  T h e  s a m e  
m a y  be t h e  case  w i t h  t h e  Epo r ecep to r ,  i n  w h i c h  t h e  P C R  
p r o d u c t  appears  as a d o u b l e  b a n d  of w h i c h  t h e  l o w e r  is 
t h e  e x p e c t e d  s ize  of m a t u r e  c D N A .  CSF-1 is a lso  i n d u c e d  
d u r i n g  t h e  p r e c u l t u r e  stage,  b u t  c a n n o t  be d e t e c t e d  at 
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Figure 4. Expression of globin and cell-surface marker genes during ES cell differentiation analyzed by RT-PCR. Ethidium bromide 
stain of the amplification products of fetal [3-globin lY), adult B-globin (bl), CD45, and Thy-1. All amplifications were performed for 
35 cycles with the exception of CD45, which was carried out for 45 cycles. The distribution of the samples on the gels is the same for 
every RT-PCR presented in this report and is always shown for the upper row of gels. Sample numbers are indicated in the lower row. 
The specific gene that was detected in any given PCR is denoted for every gel. Here, we show two sets of controls not containing 
reverse transcriptase during the first-strand synthesis (neg. control) for fetal B-globin and adult 13-globin. These negative control 
examples are characteristic for all of the other amplifications. It is obvious that the negative control amplifies only the band derived 
from the genomic DNA (arrow}, whereas the cDNA band (arrowhead} is absent in this control. For our other results we present only 
the reverse transcriptase positive samples. 
day 2, and then reappears on day 4. We do not know 
whether  this phenomenon,  which was also observed 
wi th  other genes, is due to natural  regulation or whether  
it is at t r ibutable to the temporary shock of transferring 
the cells from the preculture to the differentiation cul- 
ture, but  it is interesting that  so far this phenomenon has 
only been observed wi th  factors. The nature  of the 450- 
bp band amplified in the CSF-1 PCR from STO cells is 
not  known, but it hybridizes under  stringent conditions 
to the CSF-1 probe {data not  shown). The CSF-1 receptor 
is expressed weakly  at day 8 and strongly from day 12 on. 
There was no evidence of GM-CSF expression in the dif- 
ferentiated ES cells even after hybridizat ion {Fig. 5). In 
contrast,  GM-CSF m R N A  was readily detected in the 
LPS-stimulated spleen and STO cell controls. The sen- 
sitivity of our PCR reactions is such (see Materials  and 
methods} that  we can conclude that  there is no function- 
ally significant expression of GM-CSF in differentiating 
ES cell cultures. 
Although there was a t ransient  low-level expression of 
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Figure 5. Expression of genes coding for CSFs and their receptors during ES cell differentiation analyzed by RT-PCR. Ethidium 
bromide stain or hybridization of the amplification products of CSF-1, CSF-1 receptor, GM-CSF, G-CSF, G-CSF receptor, Epo, and Epo 
receptor. All amplifications were performed for 50 cycles with the exception of CSF-1 and Epo, which were carried out for 35 and 40 
cycles, respectively. The arrow indicates the genomic DNA band; the arrowhead indicates the eDNA band. 
G-CSF in the preculture stage, the first significant ex- 
pression of mature fully processed mRNA was only de- 
tected on day 20, whereas transcription of its receptor 
was detected as early as day 12 (Fig. 5). The G-CSF RT- 
PCR shows three bands, all of which are reverse tran- 
scriptase dependent and hybridize under stringent con- 
ditions to a G-CSF-specific oligonucleotide: (1) the fully 
processed cDNA band of 427 bp expressed at high levels 
only at day 24 of ES cell development and in LPS-acti- 
vated spleen cells; (2) a band that is the same size as the 
primary genomic transcript expressed throughout most 
of the time course; and (3) a band of -650 bp that is 
slightly smaller than the primary transcript and may be 
a splicing intermediate. These three bands were consis- 
tently observed with four different G-CSF-specific 
primer pairs (data not shown). The fact that mature 
mRNA is not seen in every sample that contains the 
primary genomic transcript and that the presumed splic- 
ing intermediate is only observed in samples that have 
the mature transcript suggests that the splicing of the 
G-CSF primary transcript is developmentally well regu- 
lated. 
The transcription of the G-CSF receptor demonstrates 
a strong cyst to noncyst difference (Fig. 5). The majority 
of G-CSF receptor mRNA expression occurs in the cyst 
fraction, whereas it is not detected in the noncysts until 
day 24 where it is expressed at comparatively low levels. 
This selective expression is similar to our findings pre- 
sented above that the cysts contain the vast majority of 
colony-forming cells. Although not as obvious in this 
particular experiment, the CD45, IL-1 [3, and globin genes 
exhibit a similar preferential expression in cysts versus 
noncysts (Figs. 4 and 6 and E. Bruyns, unpubl.). The op- 
posite is observed with Epo, IL-I~, IL-6, and G-CSF, 
which are expressed preferentially in the noncyst frac- 
tions (Figs. 5 and 6). 
Interleukins and their receptors 
With the exception of the IL-4 receptor that is expressed 
at very low levels in some but not all undifferentiated ES 
cell samples, none of the interleukins or their receptors 
are expressed in undifferentiated ES cells (Fig. 6; Table 
2). IL-la and IL-1B, although functionally similar, are 
distinct unrelated genes and are induced at different time 
points during ES cell differentiation. IL-1B is expressed 
as early as day 12, whereas IL-I~ cannot be detected be- 
fore day 20. Although these two proteins are unrelated, 
they can bind to the same type I ("T cell"} IL-1 receptor 
(Arai et al. 1990). The gene for this IL-1 receptor has its 
major transcriptional activation starting on day 12. 
IL-4 and IL-6 have similar expression pattems, with 
both genes being expressed as early as day 2 and at the 
preculture stage, respectively (Fig. 6). Then both genes 
appear to be temporarily shut off, and no evidence for 
expression of either gene can be detected until day 12. 
The IL-4 receptor is one of the earliest cytokine receptor 
genes to be expressed and is transcribed in significant 
amounts starting with the preculture stage. The murine 
IL-6 receptor has not been cloned and could not be ana- 
lyzed. IL-3 is an interleukin that is fundamentally in- 
volved with the in vitro development of hematopoietic 
colonies and was shown to act on primitive precursor 
cells (Iscove and Roitsch 1985; Suda et al. 1985; Bodine 
et al. 1989; Iscove and Yang 19901. Even after hybridiza- 
tion and prolonged exposure, no evidence of IL-3 expres- 
sion was detected at any time during ES cell develop- 
ment nor was IL-3 message detected in normal lymphoid 
tissue (Fig. 6J. However, IL-3 was easily detected in RNA 
from the WEHI-3 cell line in which it is constitutively 
expressed {Lee et al. 19821. Because of the sensitivity of 
our PCR reactions (see Materials and methods}, we con- 
elude that IL-3 is not expressed during ES cell differen- 
tiation. In contrast to the lack of expression of the cyto- 
kine, the IL-3 receptor was first detected as early as day 
4 and continually increased its expression throughout 
the time course of the experiment (Fig. 6). A second gene 
was recently identified that is highly homologous to the 
IL-3 receptor but that does not bind IL-3 (Gorman et al. 
1990). Although our PCR and hybridization primers do 
not distinguish between these two gene products, recent 
analysis with specific primers has indicated that the 
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Figure 6. Expression of genes coding for interleukins and their receptors during ES cell differentiation analyzed by RT-PCR. Ethidium 
bromide stain or hybridization of the amplification products of: IL-la, IL-I[3, IL-1 receptor, IL-3, IL-3 receptor, IL-6, IL-4, and IL-4 
receptor. All amplifications were performed for 50 cycles with the exception of the IL-4 receptor, which was carried out for 40 cycles. 
The arrow indicates the genomic DNA band; the arrowhead indicates the cDNA band. 
temporal expression of both genes is identical. The pres- 
ence of functional IL-3 receptors is supported by the ob- 
servation that exogenous IL-3 increases the frequency of 
myeloid CFU precursors that developed during ES cell 
differentiation (unpubl.). 
Expression of SLF and c-kit 
The SLF and its receptor are critical to hematopoietic 
development. Both genes are expressed throughout the 
time course even in undifferentiated ES cells (Fig. 7). 
c-kit is expressed relatively constantly, whereas S1 un- 
dergoes a steady increase in expression up to day 24. Both 
of these genes are expressed at much higher levels than is 
seen in adult hematopoietic tissues. 
D i s c u s s i o n  
In this report we describe a novel in vitro model for 
studying hematopoietic development that is based on a 
culture system in which stable tissue culture clones of 
nonhematopoietic ES cells differentiate into mature he- 
matopoietic cells. Our results clearly document the abil- 
ity of nonhematopoietic ES cells to differentiate into 
most if not all of the hematopoietic colony-forming cells 
found in bone marrow. This conclusion is supported by 
the recent observations of Wiles and Keller { 19911. There 
is a significant difference in the frequency of hematopoi- 
etic colonies derived from normal ES cells versus bone 
marrow. ES cells give rise to a higher percentage of 
mixed and erythroid (BFU-E) colonies but fewer pure 
monocytic and pure granulocytic colonies than normal 
bone marrow (see Results). On the basis of CD45 ÷ sub- 
population, differentiating ES cells produce 35 times 
more primitive precursors of mixed and erythroid colo- 
nies than normal bone marrow, approximately equal 
numbers of precursors for dual-lineage GM-CFUs, and 
nearly eightfold fewer precursors for single lineage my- 
eloid CFUs. Approximately 1 of 100 CD45 ÷ hematopoi- 
eric cells that develop in these embryoid cysts is capable 
of forming in vitro colonies. The low number of pure 
monocytic and granulocytic colonies may represent a 
lack of appropriate cytokines, such as IL-3 {see below), to 
induce the differentiation and expansion of the more ma- 
ture CFUs, or it may suggest that immature ES cell-de- 
rived hematopoietic precursors respond differently than 
adult ceils to the factors in standard colony assays. It is 
interesting to compare these frequencies with that ob- 
served with fetal tissues. Although there is wide varia- 
tion in the published results, day-8 yolk sac cells produce 
a very high frequency, that of erythroid precursors sim- 
ilar to ES cell cultures, but on a per cell basis yolk sac 
cells produce more hematopoietic precursors than cur- 
rent ES cell cultures (Johnson and Barker 1985; Wong et 
al. 1986). The high frequency we observed within the 
hematopoietic cells of mixed CFUs that develop during 
ES cell differentiation is similar to that reported in the 
studies of yolk sac precursors by Johnson and Barker 
GENES & DEVELOPMENT 735 
 Cold Spring Harbor Laboratory Press on February 2, 2021 - Published by genesdev.cshlp.orgDownloaded from 
Schmitt  e t  al .  
i :iii :/( i ̧  
~ ~. 
Figure 7. Expression of genes coding for c-kit {SLF) during ES 
cell differentiation analyzed by RT-PCR. Ethidium bromide 
stain of the amplification products of c-kit and SLF. Amplifica- 
tions were performed for 35 cycles. 
[1985} but is quantitatively different from the results of 
Wong et al. (1986). This altered frequency of precursors 
suggests that the CFUs that develop from ES cells are 
more immature than the majority of CFUs in bone mar- 
row and indicates that the ES cell model more closely 
resembles, as would be predicted, fetal rather than adult 
hematopoietic development. 
To better understand the extent of hematopoietic de- 
velopment that occurs in ES cell differentiation cultures, 
the expression of hematopoietic cell-specific surface 
markers was evaluated. None of these markers was ex- 
pressed on undifferentiated ES cells (Table 1). CD45 (Ly- 
5), a molecule that is expressed on most mature he- 
matopoietic cells and colony-forming precursors, is ex- 
pressed on - 2 %  of the differentiated ES cells after day 16 
[Table 1}. The expression of B220, a splicing variant of 
CD45 that is specific for the B-cell lineage (Coffman and 
Weissman 1981}, is detected on 0.3-0.5% of the cells. 
The significance of this small positive signal is not yet 
known, but this result may suggest that a low level of 
lymphoid differentiation is occurring in these cultures. 
The fact that the frequency of cells expressing granulo- 
cyte (RB6-8C5} {Coffman 1982} and macrophage {MAC-l) 
[Springer et al. 1978) markers was below the detection 
threshold of flow cytometry is consistent with the low 
number of myeloid CFUs obtained from these cultures. 
The low frequency of hematopoietic cells is documented 
further by the observations that two additional determi- 
nants that have been reported to be on immature precur- 
sors; that is, AA4.1 {McKeam et al. 1985; Jordan et al. 
1990} and Ly-6 {LeClair et al. 1989; Shevach and Korty 
1989; van de Rijn et al. 1989) are present on <0.5% and 
0.8% of these cells, respectively. This low frequency is 
to be expected because of the wide range of other cell 
types produced during ES cell differentiation. 
As a first step toward understanding the molecular 
control of early hematopoietic development, we sought 
to correlate the expression of genes known to be impor- 
tant in hematopoiesis with the development of he- 
matopoietic precursors that are produced during ES cell 
differentiation. Fetal ~-globin is the predominant form 
expressed during the early stages of ES cell differentia- 
tion (preculture to day 8), whereas in methylcellulose 
cultures mature erythroid colonies switch and express 
almost exclusively the adult globin form (data not 
shown}. The transcription of both globin genes increased 
dramatically by day 12 of differentiation, which corre- 
sponded to a steep rise in hematopoietic precursor devel- 
opment [Figs. 9 and 4}. These changes in globin expres- 
sion are similar to those obtained from yolk sac precur- 
sors (Wong et al. 1982, 1986) and those recently reported 
in ES cell cultures (Lindenbaum and Grosveld 1990; 
Wiles and Keller 1991} and demonstrate that the regula- 
tion of 13-globin transcription in this in vitro system re- 
capitulates the in vivo developmental regulation (Rus- 
sell 1979). 
Cytokines and their receptors play an important role 
in hematopoietic development. Of the genes that were 
analyzed, only $1 and c-kit were expressed at any sig- 
nificant level in undifferentiated ES cells, but most of 
the other cytokine and receptor genes underwent con- 
siderable transcriptional activation during ES cell differ- 
entiation before the major onset of hematopoietic pre- 
cursor development. In most cases the receptor genes 
were transcribed before the corresponding growth factors 
[Table 2). It is informative that the growth factor recep- 
tors that are expressed on lineage-committed cells (G- 
CSF and CSF-1 receptors) appear later than the IL-3 re- 
ceptor and c-kit, which are expressed on less committed 
cells. 
Epo and IL-6 have critical roles in hematopoietic dif- 
ferentiation. Recent data suggest that Epo also stimu- 
lates endothelial development {Anagnostou et al. 1990) 
and IL-6 may be involved in angiogenesis {Motto et al. 
1990). This is directly relevant to the system described 
here because IL-6, Epo, and the Epo receptor genes show 
a very early onset of expression before hematopoietic 
development (Fig. 5), and the blood islands that form in 
the developing cysts are encased in endothelial struc- 
tures {Doetschman et al. 1985). It may be that one of the 
early functions of Epo and IL-6 is to stimulate the devel- 
opment and activation of endothelial cells that are 
known to produce many cytokines {Nicola 1989). It is 
not known what cells within the differentiating ES cul- 
tures express Epo, but during fetal development Kupffer 
cells of the reticuloendothelial system in the fetal liver 
produce this growth factor {Gruber et al. 1977}. 
In addition to the factors produced de novo by differ- 
entiating ES cells, cytokines are also supplied by the 
HCS used as a media supplement. It is clear that HCS is 
supplying important factors because of its dramatic ef- 
fects on the hematopoietic development of the ES cells, 
but it is unlikely that HCS is supplying GM-CSF, IL-3, 
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IL-4, or SLF in a functional sense because of the species 
specificity of these factors (Lee et al. 1985; Mosmann  et 
al. 1987; Otsuka  et al. 1988; Mart in  et al. 1990). There- 
fore, if these factors are to play a role they mus t  be pro- 
duced de novo. The lack of transcription of the IL-3 and 
GM-CSF genes during the in vitro hematopoiet ic  devel- 
opment  of ES cells suggests that  these two factors are not 
critical to this process. The role of IL-3 in normal  he- 
matopoiesis has been debated (Iscove and Roitsch 1985; 
Schrader et al. 1988; Whet ton and Dexter  1988). Our 
conclusion that  IL-3 does not have a role in the early 
stages of hematopoiet ic  development lends support to 
the hypothesis  that  IL-3 is necessary only in t imes of 
hematopoiet ic  crisis. SLF and its receptor (c-kit) have 
been reported to have IL-3-1ike activities on hematopoi- 
etic CFUs (Anderson et al. 1990; Mart in et al. 1990}, and 
it is possible that  they may  have a similar function dur- 
ing early hematopoiet ic  development.  The expression of 
c-kit  and S1 throughout  ES cell differentiation (Fig. 7) 
and during embryonic development (Matsui et al. 1990; 
Orr-Urtreger et al. 1990) is consistent wi th  this hypoth- 
esis. Also in this regard, the early expression of IL-6, IL-4, 
and the IL-4 receptor may  be important  (Fig. 6; Table 1). 
IL-6 enhances murine  colony formation (Wong et al. 
1988), and IL-6 in combinat ion wi th  IL-4 s t imulates  c o l  
ony formation of various hematopoiet ic  progenitor cells 
(Rennick et al. 1989). Thus, it is conceivable that  the 
combinat ion of IL-4 and IL-6 has important  synergistic 
effects on very primit ive hematopoiet ic  cells as well as 
having crucial roles, independent of hematopoiesis,  early 
in fetal development (Murray et al. 1990). 
In summary ,  we have demonstrated that  differentiat- 
ing ES cells produce most  of the hematopoiet ic  precur- 
sors that  are found in bone marrow. During their in vitro 
development,  ES cells express in a well-defined temporal  
order the genes for ~-globin, cytokines and their recep- 
tors, and surface markers  specific for hematopoiet ic  
cells. Our  data suggest that  IL-3 and GM-CSF are not 
critical to the early in vitro hematopoiet ic  development 
and that  the expression of SLF, Epo, IL-4, and IL-6 may  be 
important  during the early stages of ES cell differentia- 
tion. This novel system makes  it possible to study the 
control of growth and differentiation of mature  he- 
matopoiet ic  cells from their nonhematopoiet ic  precur- 
sors. 
Materials  and m e t h o d s  
ES cells 
The isolation of the ES cell lines was basically performed as 
described (Robertson 1987). The 1E6/2 ES cell line, used 
throughout this report, was derived from a C57BL/6J-Gpi-1 a 
mouse and maintained in Dulbecco's modified Eagle medium 
{DMEM), 20% FCS, 150 ~M ~-thioglycerol, 50 ~g/ml of genta- 
micin, and 50% of 5637 supernatant as a source of LIF {Williams 
et al. 1988). The 1E6/2 line is karyotypically normal and male 
(data not shown). These cultures always contain a small per- 
centage of differentiated ES cells; therefore, for the RNA anal- 
ysis undifferentiated ES cells were obtained by picking colonies 
with micropipettes. To initiate differentiation, precultures were 
established by transferring 2 x 10 a ES cells into new dishes 
with medium described above, and these were maintained for 
6-9 days without further feeding. The large colonies formed 
during the preculture were harvested with dispase (Collabora- 
tive Research Laboratories), washed, and transferred to bacterial 
dishes containing medium similar to that described above, ex- 
cept that 20% HCS was used in place of FCS and no LIF was 
added. The differentiation cultures were fed every 3 days by 
replacing half of the medium. Single-cell suspensions were pre- 
pared, from the entire cultures (days 0-8) or separately from the 
macroscopically visible cysts and noncysts (days 12-28), by gen- 
tle mechanical agitation in PBS containing 0.25% trypsin- 
EDTA (Sigma). 
In vitro colony assay 
Methylcellulose cultures were performed essentially as de- 
scribed (Iscove 1984) with FCS (4%) and optimal concentrations 
of recombinant erythropoietin (Genetics Institute), IL-3 (Kara- 
suyama and Melchers 1988), and 5637 supematant as a source of 
IL-1 {Mochizuki et al. 1987). Colonies were counted after 8 and 
12 days. Colony types were determined by morphology, and 
confirmed by cytological examination of May-Griinwald- 
Giemsa-stained colony smears. 
FA CS analysis 
Standard two-stage immunofluorescence was performed using 
optimal concentrations of primary antibodies against CD45 
(M1/9.3) {Springer et al. 1978), MAC-1 (M1/70.15.1) (Springer et 
al. 1978), B220 (14.8) (Kincade et al. 1981), RB6-8C5 (Coffman 
1982), Thy- 1.2 (30-H12) (Ledbetter and Herzenberg 1979), Ly-6 
(E13161-7) (Aihara et al. 1986), and AA4.1 (McKearn et al. 1984). 
The second stage was FITC-coupled F(ab)2 fragments of goat- 
anti-rat immunoglobulin (Jackson Immunoresearch Laborato- 
ries). The cells were analyzed on a modified Coulter Epics V 
system. Negative controls were incubated with irrelevant iso- 
type-matched controls and the second-stage antibody. 
RNA isolation and cDNA synthesis 
Total RNA was isolated by the acid phenol procedure {Chom- 
czynski and Sacchi 1987). The first-strand cDNA reaction was 
performed using Moloney murine leukemia virus {Mo-MLV) re- 
verse transcriptase (BRL) according to the manufacturer's pro- 
tocol with 15 units of RNA guard and 20 pmoles of random hex- 
amer primers (Pharmacia) in a 40-~1 reaction. This reaction con- 
tained -20  ng of total RNA, which represents approximately 
the equivalent of 2 x 103 cells. The same first-strand prepara- 
tion was used for analyzing each of the genes. To control for 
template or other contaminations that would interfere with the 
PCR results, one first-strand reaction contained no RNA tem- 
plate (lane 15) and duplicates of each reaction were performed 
without reverse transcriptase (Figs. 3 and 4). 
PCR 
PCR amplifications (Saiki et al. 1988) were performed with 
2.5% of the first-strand reaction product with Taq polymerase 
(2.5 units) (Promega) according to the manufacturer's protocol 
using 50 pmoles of each of the two gene-specific amplimers 
(Table 3) in a reaction volume of 100 ~1. Most PCRs were as- 
sayed at two different cycle numbers by removing one-half of 
the reaction volume at appropriate times during the amplifica- 
tion. This allowed for the control of "saturation effects" of the 
PCR, which made it possible to better judge quantitative differ- 
ences between samples. The reactions were carried out in a 
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Table 3. Oligonucleotide primers for studying gene expression during in vitro differentiation of ES cells 























f~-Globin (bl) (adult) 
f~-Actin 
A A G G A G A G C C G G G T G A C A G T A T  
T A G G C T C A T C T G G G A T C C T C T C  
C T G T T G G T G A G G A A T G T G G C T G  
T T C T T G C C A G C T C T A C C A C C A G  
T T C C T T T G G G C T C T T C T A T C G C  
T C T G T A G G G C T T C C A A G G T G C T  
C T G T G G G C T G T C T G A T T T T G C T  
A A C C A C G G C C T T C C C T A C T T C A  
G T C A G A A C A C T G T A G C C A C A T G  
G C G A T G T G T G A G C A A T G G C A G T  
C C A A C T T T G C C A C C A C C A T C T G  
C C C C T C A A A C C T A T C C T G C C T C  
TGAGGAGGATGTGGCTGCAGAA 
A C G T C C C A C C C T G C T G C T T T T A  
T T C T C C T C G C T A T C A C C G C A T C  
C A A C A G C A A T G G C C T C A C G A G T  
C G C T G C C T T T C C T T A T G A A G A A G A  
C C T G A G T C T G C A T C T A A A C C C C  
A C A G C C T G C C T G G T G A A C C A A A  
A A C C C T C A T C A A T G G C C T G T G G  
A T G G T G C A C C T G A C T G A T G C T G  
GTGACGAGGCCCAGAGCAAGAG 
G A T G C C T G T C A A G C T C A G A G G A  1270 
T A C C A G T T G G G G A A C T C T G C A G  770 
A G C C G T G A G G A T G A T A A A G C C C  501 
A C T T T A G G T G C T C T G C C T G C T G  522 
CCAGGAGCAAGGTGAAGATGAG 554 
G A T G C T C T T T A G G C T T T C C A G G  191 
T C C T G G C T T C G G G T C T G C T T A T  856 
G C A T A A C G C A C T A G G T T T G C C G  585 
C T G T C A A C G G C C T G T C T G T T A T  993 
A G A C C G T T T T G C G T A A G A C C T G  341 
G G A G C A G C A G C A G G A A T C A A T A  427 
T C C A G G C A G A G A T G A G C G A A T G  567 
T G T G C C A C A T C T C T T G G T C C C T  544 
C G T G T A C A G C T T C A G T T T C C C C  532 
C C T C A A A C T C G C T C T C T G G G C T  497 
G T G G T A C A C C T T T G C T C T G C T C  1069 
C G G G A C C T A A T G T T G A A G A G A G C A  528 
T G C T T G G C C A G T A T T C T G C G C A  1067 
G G C C C A A C C A G T C A C A G A G A A A  423 
T C A G T G G T A C T T G T G G G A C A G C  415 
G G T T T A G T G G T A C T T G T G A G C C  444 
A G G G G C C G G A C T C A T C G T A C T C  934 
a Size of the amplified cDNA product in base pairs. 
Cetus thermocycler for 25-50 cycles consisting of 1' 94°C, 1' 
60-65°C {depending on the melting temperature of the primer 
pair), 2' 72°C with 2" increments per cycle. The specificity of 
the PCR product was established by comparing the size of the 
amplified product to the expected eDNA band, and most were 
hybridized with an internal oligonucleotide. As an internal 
standard, all eDNA samples were adjusted to yield relatively 
equal amplification of 13-actin {Fig. 3). Densitometric analysis of 
the t3-actin amplification revealed that the samples had a coef- 
ficient of variance of 0.34 (data not shown) that was insignifi- 
cant compared with the changes in message levels observed 
during differentiation for the other genes. Figure 4 shows the 
reverse transcriptase-negative control, a control performed in 
all PCR experiments, for the globin genes, which amplifies con- 
taminating DNA (genomic or otherwise) in the RNA prepara- 
tion. The sensitivity of our PCR reaction was estimated by ti- 
trating a known number of synthetic RNA molecules with the 
relevant primer sites into a first-strand reaction with RNA 
known to be negative for the message of interest (Wang et al. 
1989). This technique controls for the efficiency of the first- 
strand synthesis as well as the amplification efficiency of the 
specific primer pairs used. These experiments indicate that by 
ethidium bromide-stained gels we can reproducibly detect IL-3 
or GM-CSF by analyzing one-third of our standard PCR reaction 
in which the eDNA derived from 10-100 RNA molecules was 
amplified (data not shown). This sensitivity is generally in- 
creased by at least a factor of 10 by hybridization with 12- to 
48-hr exposure times. There was no detectable expression of 
IL-3 or GM-CSF in differentiating ES cultures even after 12-14 
days of exposures. 
Analysis of PCR products 
An aliquot of each PCR reaction was separated on agarose gels, 
and the DNA was blotted with 0.4 N NaOH onto Zeta probe 
membranes (Bio-Rad). The blots were hybridized with internal 
oligonucleotides, unrelated to the PCR primers, specific for the 
respective amplification product, and washed at a final strin- 
gency of 20 mM Tris-HC1 (pH 8), 100 mM NaC1, 0.6 mM EDTA, 
and 0.1% SDS at 2-5°C below the melting temperature of the 
probe. 
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